A humoral response to oligodendrocyte-specific protein in MS: A potential molecular mimic

Neurology

Volumn 53, Issue 1, 1999, Pages 154-161

  Bronstein, Jeff M ^a   Lallone, R L ^b,c   Seitz, R S ^b   Ellison, G W ^a   Myers, L W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Research Genetics   (United States)

^c Brookwood Biomedical   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY;

ADULT; AGED; ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOBLOTTING; MALE; MULTIPLE SCLEROSIS; OLIGODENDROGLIA; PRIORITY JOURNAL; RECURRENT DISEASE;

EID: 0033551485     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.53.1.154     Document Type: Article

References (41)

1. Olsson T. Multiple sclerosis: cerebrospinal fluid. Ann Neurol 1994;36:S100-S102.
2. Zhou SR, Whitaker JN, Wood DD, Moscarello MA. Immunological analysis of the amino terminal and the C8 isomer of human myelin basic protein. J Neuroimmunol 1993;46:91-96.
3. Johnson D, Hafler DA, Fallis RJ, et al. Cell-mediated immunity to myelin-associated glycoprotein, proteolipid protein, and myelin basic protein in multiple sclerosis. J Neuroimmunol 1986;13:99-108.
4. Sun JB, Olsson T, Wang WZ, et al. Autoreactive T and B cells responding to myelin proteolipid protein in multiple sclerosis and control subjects. Eur J Immunol 1991;21:1461-1468.
5. Sun J, Link H, Olsson T, et al. T and B cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis. J Immunol 1991;146:1490-1495.
6. van Noort JM, van Sechel AC, Bajramovic JJ, et al. The small heat-shock protein alpha B-crystallin as candidate autoantigen in multiple sclerosis. Nature 1995;375:798-801. See comments.
7. McFarland HF, Dhib-Jalbut S. Multiple sclerosis: possible immunological mechanisms. Clin Immunol Immunopathol 1989; 50:S96-S105.
8. Gerritse K, Deen C, Fasbender M, et al. The involvement of specific anti myelin basic protein antibody-forming cells in multiple sclerosis immunopathology. J Neuroimmunol 1994; 49:153-159.
9. Warren KG, Catz I, Johnson E, Mielke B. Anti-myelin basic protein and anti-proteolipid protein specific forms of multiple sclerosis. Ann Neurol 1994;35:280-289.
10. Xiao BG, Linington C, Link H. Antibodies to myelin-oligodendrocyte glycoprotein in cerebrospinal fluid from patients with multiple sclerosis and control subjects. J Neuroimmunol 1991; 31:91-96.
11. Lisak RP, Zweiman B, Burns JB, Rostami A, Silberberg DH. Immune responses to myelin antigens in multiple sclerosis. Ann NY Acad Sci 1984;436:221-230.
12. Simon J, Simon O. Effect of passive transfer of anti-brain antibodies to a normal recipient. Exp Neurol 1975;47:523-534.
13. Jancovic BD, Drasskoci M, Vanjic M. Passive transfer of "allergic" encephalomyelitis with antibrain serum injected into the lateral ventricle of the brain. Nature 1965;207:428. Letter.
14. Linington C, Engelhardt B, Kapocs G, Lassman H. Induction of persistently demyelinated lesions in the rat following the repeated adoptive transfer of encephalitogenic T cells and demyelinating antibody. J Neuroimmunol 1992;40:219-224.
15. Genain CP, Nguyen MH, Letvin NL, et al. Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate. J Clin Invest 1995;96:2966-2974.
16. Challoner PB, Smith KT, Parker JD, et al. Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc Natl Acad Sci USA 1995;92:7440-7444.
17. Wucherpfennig KW, Strominger JL. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 1995;80: 695-705.
18. Banki K, Colombo E, Sia F, et al. Oligodendrocyte-specific expression and autoantigenicity of transaldolase in multiple sclerosis. J Exp Med 1994;180:1649-1663.
19. Bronstein JM, Popper P, Micevych PE, Farber DB. Isolation and characterization of a novel oligodendrocyte-specific protein. Neurology 1996;47:772-778.
20. Bronstein JM, Micevych PE, Chen K. Oligodendrocyte-specific protein (OSP) is a major component of CNS myelin. J Neurosci Res 1997;50:713-720.
21. Stevens DB, Chen K, Sercarz EE, Bronstein JM. Oligodendrocyte-specific protein (OSP) peptides are encephalitogenic in SJL mice. J Immunol 1999 (in press).
22. Schumacher GA, Beebe G, Kibler RF, et al. Problems of experimental trials of therapy in multiple sclerosis: report by the panel on the evaluation of experimental trials of therapy in multiple sclerosis. Ann NY Acad Sci 1965;122:552-568.
23. Tourtellotte WW, Tavolato B, Parker JA, Comiso P. Cerebrospinal fluid electroimmunodiffusion. An easy, rapid, sensitive, reliable, and valid method for the simultaneous determination of immunoglobulin-G and albumin. Arch Neurol 1971;25: 345-350.
24. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227: 680-685.
25. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with Folin phenol reagent. J Biol Chem 1951; 193:265-275.
26. Kyte J, Doolittle RF. A simple method for displaying the hydropathic character of a protein. J Mol Biol 1982;157:105-132.
27. Bronstein JM, Kozak CA, Chen X, et al. Chromosomal localization of murine and human oligodendrocyte-specific protein genes. Genomics 1996;34:255-257.
28. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-231.
29. Bernard CC, de Rosbo NK. Immunopathological recognition of autoantigens in multiple sclerosis. Acta Neurol (Napoli) 1991; 13:171-178.
30. de Rosbo NK, Bernard CC. Multiple sclerosis brain immunoglobulins stimulate myelin basic protein degradation in human myelin: a new cause of demyelination. J Neurochem 1989;53:513-518.
31. Link H, Baig S, Olsson O, et al. Persistent anti-myelin basic protein IgG antibody response in multiple sclerosis cerebrospinal fluid. J Neuroimmunol 1990;28:237-248.
32. Panitch HS, Hooper CJ, Johnson KP. CSF antibody to myelin basic protein. Measurement in patients with multiple sclerosis and subacute sclerosing panencephalitis. Arch Neurol 1980;37:206-209.
33. Archelos JJ, Trotter J, Previtali S, Weissbrich B, Toyka KV, Hartung HP. Isolation and characterization of an oligodendrocyte precursor-derived B-cell epitope in multiple sclerosis. Ann Neurol 1998;43:15-24.
34. Buznikov A, Vu T, Kornblum H, Chen K, Bronstein JM. Cloning of the human oligodendrocyte-specific protein (OSP) homologue. Soc Neurosci 1996;776:2. Abstract.
35. Matsui M, Nagumo F, Tadano J, Kuroda Y. Characterization of humoral and cellular immunity in the central nervous system of HAM/TSP. J Neurol Sci 1995;130:183-189.
36. Rose NR, Wolfgram LJ, Herskowitz A, Beisel KW. Postinfectious autoimmunity: two distinct phases of Coxsackie virus B3-induced myocarditis. Ann NY Acad Sci 1986;475:146-156.
37. Ray CG, Palmer JP, Crossley JR, Williams RH. Coxsackie B virus antibody responses in juvenile-onset diabetes mellitus. Clin Endocrinol (Oxf) 1980;12:375-378.
38. Husby G, van de Rijn I, Zabriskie JB, Abdin ZH, Williams RC Jr, Antibodies reacting with cytoplasm of subthalamic and caudate nuclei neurons in chorea and acute rheumatic fever. J Exp Med 1976;144:1094-1110.
39. Maclaren NK, Alkinson MA. Insulin-dependent diabetes mellitus: the hypothesis of molecular mimicry between islet cell antigens and microorganisms. Mol Med Today 1997;3:76-83.
40. Kurtzke JF. Epidemiology of multiple sclerosis. In: Vinken PJ, Bruyn GW, Klawans HL, Koetsier JC, eds. Handbook of clinical neurology. New York: Elsevier Science Publishing, 1985: 259-287.
41. Lehmann PV, Sercarz EE, Forsthuber T, Dayan CM, Gammon G. Determinant spreading and the dynamics of the autoimmune T-cell repertoire. Immunol Today 1993;14:203-208. See comments.